Peptide Identity by Mass Spectrometry: What a Match Means
Understand peptide mass spectra, charge states, intact mass and sequence evidence, including identity questions a simple mass match cannot resolve.

Mass spectrometry supports peptide identity by measuring ions and comparing the resulting mass information with an expected molecular specification. Intact-mass agreement is useful, but it does not establish every residue position, stereochemical feature or crosslink. Read a mass spectrum as evidence answering a defined question, rather than as a universal “identity confirmed” stamp. [1]
Why the horizontal axis says m/z
The axis describes mass-to-charge information for ions. It is not simply the neutral molecular weight printed on a product label. Charge assignment, ion type and data processing matter when relating a measured peak to the proposed molecule. IUPAC defines the m/z terminology and its charge-number basis. [1]
For illustration only, take a hypothetical neutral molecule of mass 1,000.000 Da. If the detected species is a doubly protonated ion, its approximate m/z is (1,000.000 + 2 × 1.0073) ÷ 2 = 501.0073. A peak near 501 is not automatically evidence for a separate 501-Da compound. This arithmetic assumes that ion assignment; it is not a measured spectrum or a calibration rule.
Intact mass and sequence evidence answer different questions
| Evidence | What it can support | Important limitation |
|---|---|---|
| Intact-mass agreement | Consistency with an expected molecular mass | Different structures can have the same mass |
| Tandem MS fragmentation | Sequence-related assignments from fragment patterns | Coverage and the particular fragmentation method matter |
| Chromatographic separation coupled to MS | Mass information associated with separated components | Separation and ion response are still method-dependent |
| Other structural methods | Additional evidence for a defined structural uncertainty | Must be selected for the actual ambiguity |
Do not describe an intact-mass result as “complete sequencing” unless sequence analysis was actually performed and documented.
The leucine–isoleucine example
Leucine and isoleucine are a useful demonstration of the problem. They have the same residue mass, so an intact-mass match cannot distinguish a Leu-to-Ile substitution. Researchers have developed specialised approaches for this question: a 2006 study used low-energy ion-trap MSn, and a later integrated LC-MS approach demonstrated Leu/Ile assignment using additional analytical information. These papers do not support saying that every routine mass spectrum distinguishes the pair. [2] [3]
An even simpler hypothetical example is a pair of linear peptides containing the same residues in different orders. Their intact masses can agree while their sequences differ. That is why the complete sequence specification and the scope of the analytical method should be assessed together.
What should an identity report let you compare?
- Expected structure: sequence, terminal chemistry and other stated modifications.
- Mass convention: whether the expected value and reported result are directly comparable.
- Ion assignment: charge state, adduct interpretation or a documented deconvolution result.
- Observed result: measured value and an appropriate stated acceptance criterion.
- Sample traceability: the submitted sample, batch reference and analysis date.
- Unresolved questions: structural features not addressed by the procedure.
This list is a document-reading aid, not a universal release specification. Acceptance criteria must suit the method and intended purpose; a tolerance should not be invented after seeing the result.
Why MS identity is not a purity percentage
A spectrum showing the expected ion is not, on its own, a validated mass-fraction assay for everything in a vial. ICH distinguishes identity, impurity testing and assay as different analytical purposes. Additional procedures may be needed to answer separate quality questions. [4]
For the complementary separation question, see how to interpret a peptide HPLC chromatogram. For report scope and batch context, use the COA reading guide.
Common questions
Does matching molecular weight prove the entire structure?
No. Matching mass narrows an identity question but does not resolve all possible structural alternatives.
Does every additional peak mean a contaminant?
No. Before assigning a separate compound, consider the ion interpretation and the analysis method. Do not label an unexplained signal as either contamination or harmless without evidence.
Continue through the peptide science guide for the relationship between molecular specifications, analytical data and research findings.
Scope: educational interpretation of published methods and research. HealthyWelness operates a commercial research-material catalog. Examples are not batch test results, product endorsements or personal-use guidance. Cover: AI-generated conceptual editorial artwork, not an exact molecular structure, experimental data or a photograph of HealthyWelness facilities.
Sources
- IUPAC Gold Book: Mass-to-charge ratio (M03752)
- How to discriminate between leucine and isoleucine by low energy ESI-TRAP MSn (2006), PMID 17010643
- Distinguishing between Leucine and Isoleucine by Integrated LC-MS Analysis Using an Orbitrap Fusion Mass Spectrometer (2016), PMID 27704771
- FDA: Q2(R2), Validation of Analytical Procedures (2024)